These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33626278)

  • 1. Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell.
    Knerr L; Prakash TP; Lee R; Drury Iii WJ; Nikan M; Fu W; Pirie E; Maria L; Valeur E; Hayen A; Ölwegård-Halvarsson M; Broddefalk J; Ämmälä C; Østergaard ME; Meuller J; Sundström L; Andersson P; Janzén D; Jansson-Löfmark R; Seth PP; Andersson S
    J Am Chem Soc; 2021 Mar; 143(9):3416-3429. PubMed ID: 33626278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of antisense oligonucleotides to pancreatic β-cells.
    Ämmälä C; Drury WJ; Knerr L; Ahlstedt I; Stillemark-Billton P; Wennberg-Huldt C; Andersson EM; Valeur E; Jansson-Löfmark R; Janzén D; Sundström L; Meuller J; Claesson J; Andersson P; Johansson C; Lee RG; Prakash TP; Seth PP; Monia BP; Andersson S
    Sci Adv; 2018 Oct; 4(10):eaat3386. PubMed ID: 30345352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides.
    Nikan M; Tanowitz M; Dwyer CA; Jackson M; Gaus HJ; Swayze EE; Rigo F; Seth PP; Prakash TP
    J Med Chem; 2020 Aug; 63(15):8471-8484. PubMed ID: 32677436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.
    Jo S; Chen J; Xu G; Grayson TB; Thielen LA; Shalev A
    Diabetes; 2018 Feb; 67(2):256-264. PubMed ID: 29101219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent exendin-4 derivatives for pancreatic β-cell analysis.
    Clardy SM; Keliher EJ; Mohan JF; Sebas M; Benoist C; Mathis D; Weissleder R
    Bioconjug Chem; 2014 Jan; 25(1):171-7. PubMed ID: 24328216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NanoSIMS Imaging Reveals the Impact of Ligand-ASO Conjugate Stability on ASO Subcellular Distribution.
    Kay E; Stulz R; Becquart C; Lovric J; Tängemo C; Thomen A; Baždarević D; Najafinobar N; Dahlén A; Pielach A; Fernandez-Rodriguez J; Strömberg R; Ämmälä C; Andersson S; Kurczy M
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes.
    Kinberger GA; Prakash TP; Yu J; Vasquez G; Low A; Chappell A; Schmidt K; Murray HM; Gaus H; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3690-3. PubMed ID: 27268307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion?
    van Raalte DH; Verchere CB
    Trends Endocrinol Metab; 2016 Jul; 27(7):442-445. PubMed ID: 27160799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor.
    Girdhar K; Thakur S; Gaur P; Choubey A; Dogra S; Dehury B; Kumar S; Biswas B; Dwivedi DK; Ghosh S; Mondal P
    J Biol Chem; 2022 May; 298(5):101889. PubMed ID: 35378127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands Targeting Apolipoprotein B.
    Watanabe A; Nakajima M; Kasuya T; Onishi R; Kitade N; Mayumi K; Ikehara T; Kugimiya A
    J Pharmacol Exp Ther; 2016 May; 357(2):320-30. PubMed ID: 26907624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice.
    Watanabe A; Katsube T
    Biopharm Drug Dispos; 2021 Apr; 42(4):178-187. PubMed ID: 33724506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
    Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N
    J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression.
    Kulkarni RN; Smith DM; Ghatei MA; Jones PM; Bloom SR
    J Endocrinol; 1996 Dec; 151(3):341-8. PubMed ID: 8994379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure.
    Liu Y; Rodriguez L; Wolfe MS
    Bioorg Chem; 2014 Jun; 54():7-11. PubMed ID: 24691171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
    Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
    Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.